tetano
Editor, Senior Moderator
J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25835. [Epub ahead of print]
A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults.
Han YN[SUP]1[/SUP], Feng ZW[SUP]2[/SUP], Sun LN[SUP]1[/SUP], Ren XX[SUP]1[/SUP], Wang H[SUP]1[/SUP], Xue YM[SUP]3[/SUP], Wang Y[SUP]4[/SUP], Fang Y[SUP]1[/SUP].
Author information
Abstract
Acute respiratory disease (ARD) caused by 2019 novel coronavirus (2019-nCoV) has rapidly spread throughout China. Children and adults show a different clinical course. The purpose of the current study is to comparatively analyze the clinical characteristics of 2019-nCoV infection in children and adults and to explore the possible causes for the discrepancies present. The medical records of 25 adults and 7 children confirmed cases of 2019-nCoV ARD were reviewed retrospectively. All children were family clusters. The total adult patients were differentiated into: the local residents of Wuhan, a history of travel to Wuhan and direct contact with people from Wuhan. The numbers were 14 (56%), 10 (40%) & 1 (4%), respectively. The median incubation period of children and adults was 5 days (range 3-12 days) and 4 days (range 2-12 days), respectively. Diarrhoea and/or vomiting (57.1%) were more common in children, whereas for adults it was myalgia or fatigue (52%). On admission, the percentage of children having pneumonia (5, 71.4%) was roughly the same as adults (20, 80%). 20% of adults had leucopoenia, but leukocytosis was more frequently in children (28.6%, P=0.014). A higher number of children had elevated creatine kinase isoenzyme (57.1% vs. 4%, P=0.004). Antiviral therapy was given to all adult patients but to none of the children. In summary, knowledge of these differences between children and adults will not only be helpful for the clinical diagnosis of 2019 novel coronavirus disease (COVID-19), but also for a future discussion on age-specific coronavirus infection. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
2019 novel coronavirus; clinical manifestations; comparative analysis; differences between children and adults; laboratory parameters
PMID:32249943DOI:10.1002/jmv.25835
A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults.
Han YN[SUP]1[/SUP], Feng ZW[SUP]2[/SUP], Sun LN[SUP]1[/SUP], Ren XX[SUP]1[/SUP], Wang H[SUP]1[/SUP], Xue YM[SUP]3[/SUP], Wang Y[SUP]4[/SUP], Fang Y[SUP]1[/SUP].
Author information
Abstract
Acute respiratory disease (ARD) caused by 2019 novel coronavirus (2019-nCoV) has rapidly spread throughout China. Children and adults show a different clinical course. The purpose of the current study is to comparatively analyze the clinical characteristics of 2019-nCoV infection in children and adults and to explore the possible causes for the discrepancies present. The medical records of 25 adults and 7 children confirmed cases of 2019-nCoV ARD were reviewed retrospectively. All children were family clusters. The total adult patients were differentiated into: the local residents of Wuhan, a history of travel to Wuhan and direct contact with people from Wuhan. The numbers were 14 (56%), 10 (40%) & 1 (4%), respectively. The median incubation period of children and adults was 5 days (range 3-12 days) and 4 days (range 2-12 days), respectively. Diarrhoea and/or vomiting (57.1%) were more common in children, whereas for adults it was myalgia or fatigue (52%). On admission, the percentage of children having pneumonia (5, 71.4%) was roughly the same as adults (20, 80%). 20% of adults had leucopoenia, but leukocytosis was more frequently in children (28.6%, P=0.014). A higher number of children had elevated creatine kinase isoenzyme (57.1% vs. 4%, P=0.004). Antiviral therapy was given to all adult patients but to none of the children. In summary, knowledge of these differences between children and adults will not only be helpful for the clinical diagnosis of 2019 novel coronavirus disease (COVID-19), but also for a future discussion on age-specific coronavirus infection. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
2019 novel coronavirus; clinical manifestations; comparative analysis; differences between children and adults; laboratory parameters
PMID:32249943DOI:10.1002/jmv.25835